He was born in 1967 in Logroño (Spain). He completed my undergraduate program in Medicine at the University of Zaragoza (Spain) (1985-91). He obtained a grant from the University of Zaragoza to attend the “Unité 14 d’ Investigation de l’INSERM” á Nancy, Hôpital de Brabois (France) in my last undergraduate summer, involved on a research program about the performance to exercise on different hypoxic conditions in rats. He passed the Spanish National Medical Exam to choosing the Intensive Care Medicine Specialty at “Hospital Clínico San Carlos” in Madrid (Spain) (1992-1996). Then He worked as Attending Physician at the Intensive Care Department of “Hospital Universitario de Canarias” (Spain) (1997-1999). He was moved to “Hospital Clínico San Carlos” (Madrid) as Attending Physician (1999-2001) and later to “Hospital Universitario Príncipe de Asturias” (Alcalá de Henares, Madrid) (2001-2005). He obtained MD degree in 2002 at the University of Zaragoza investigating how the polymorphisms of several cytokines involved in the inflammatory response to the cardiopulmonary bypass in patients operated on cardiac diseases influence the low output postoperative state. Finally, He came back to my current position at Hospital Clínico San Carlos in 2005 as Attending Physician and Chief of Medical Residents (2007-2016). He have been Associate Professor in Medicine at Universidad Complutense (Madrid) since 2011. In January 2017 He was appointed Chief of the Medical-Surgical Unit of the Intensive Care Department at “Hospital Clínico San Carlos”, Madrid. He is a member of the Spanish Society of Intensive Care Medicine (SEMICYUC), European Society of Intensive Care Medicine (ESICM) and the Regional Intensive Care Society of Madrid (SOMIAMA) (President from 2014 to 2016 and Vicepresident 2012-2014). Since 2015 I am one of the examiners of the European Diploma in Intensive Care Medicine (EDIC).
Fernando Martínez Sagasti interest includes of interest are infection; Pharmacokinetics/pharmacodynamics of antibiotics in critical patients; Sepsis and septic shock; Role of the new rapid diagnostic tests based on the identification of resistance genes; Respiratory failure and the role of biomarkers in the critical setting.